| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |